Scientific Program
9:00 – 9:15
WELCOME
F. Fanelli, P. Schneider, T. Zeller
9:15 -10:00
SESSION 1
FEMORO-POPLITEAL
Expert’s Round Table
EVOLUTION OF SFA THERAPY: WHERE WE WERE IN PAST YEARS AND WHERE ARE WE GOING?
Moderators:
B. Katzen – M. Dake
Crackers:
K. Deloose – M. Brodmann
| Y. Soga | How does IVUS guide my treatment choices? (include OFDI) Can it improve lesion specific therapy? |
| M.Lichtenberg | Vessel preparation: This is how I decide on plain balloon vs specialty balloon vs IVL vs atherectomy |
| J. Laird | DCB State-of-the art in SFA treatment after 25 years of experience |
| G. Adams | Scaffolds in the SFA-How I decide what to use and when, will it change with BRS? |
10.00 -11.00
SESSION 2
PULMONARY EMBOLISM
Expert Snapshots
HIGH-RISK PE: ACTING FAST, ACTING RIGHT
Moderators:
C. Fraccaro – H. Kobeiter
Crackers:
A. Rolandi – P. Pruszczyk
| S. Ewen | When thrombolysis is not an easy call: quantifying bleeding risk in high-risk PE |
| M. DeBucourt | Interventions in hemodynamic instability: tips and tricks for procedural success |
| M. Iannaccone | Live in the Box: mechanical thrombectomy in high risk PE |
| V.Kostantinides | High-risk PE procedures: how much is enough? defining success and stopping rules |
11:00 -11:30
COFFEE BREAK
11:30 – 12:30
SESSION 3
BELOW-THE-KNEE
Expert Snapshots
BTK: GREAT SUCCESSES, SURPRISE SUCCESSES AND LESSON LEARNED
Moderators:
E. Secemsky – Y. Soga
Crackers:
Y. Goeuffic – M. Palena
| B. Migliara | Technical tips: Novel methods of crossing and dilating |
| A. Holden | BTK vessel prep-serranator, javelin, spur and other tools-do they make a difference |
| T. Zeller | Live in the Box: local lyisis in calcium |
| S. Kum | This is my DVA technique: step by step |
12:30 – 13:15
SESSION 4
AV DIALYSIS FISTULA
Expert Snapshots
OPTIMAL TREATMENT FOR AV STENOSIS
Moderators:
D. Rajan – G. Sengoelge
Crackers:
P. Kitrou – T. Steinke
| O. Jaffer | PTA results are better than we thought and should be the go-to for AVF stenosis |
| R. Shahverdian | Is PTA of AVF stenosis enough? |
| A. Holden | DCBs are the obvious way to achieve great results |
| B. Dolmatch | Covered stents are better than everything else |
13:15 – 14:15
LUNCH
14:15 – 15:15
SESSION 5
VENOUS
Expert Snapshots
SYMPTOMATIC LEG DVT #1
Moderators:
E. Murphy – M. Lugli
Crackers:
D. Rajan – D. Baccellieri
| M.Lichtemberg | When is lower extremity DVT catheter directed thrombolysis needed and what/when is the end-point? |
| G. Richter | Thrombolysis or mechanical thrombectomy? How do we know what to do and is it cost effective? |
| G. O’Sullivan | Live in the Box: DVT treatment |
| S. Black | Literature review: where and when to stent, where to avoid stenting |
15:15 – 16:15
SESSION 6
FEMORO-POPLITEAL
Expert’s Snapshots
SFA: DEALING WITH HEAVY CALCIUM
Moderators:
M. Lichtenberg – R. Varcoe
Crackers:
E. Secemsky – M. Dake
| P. Krishnan | PTAB: Who should get this treatment option and these are my tips for getting good results |
| F. Fanelli | Atherectomy: What type do I choose and technical pearls for success |
| S. Kum | Live in the Box: how I manage occlusion of the SFA origin, especially flush occlusion |
| A. Schmidt | Algorithm for crossing and treating femoral-popliteal disease that is horribly calcified |
16:15 – 16:45
COFFEE BREAK
16:45 – 17:30
SESSION 7
PULMONARY EMBOLISM
Expert’s Round Table
CONTROVERSIAL PATHWAYS IN PE: BRIDGING EVIDENCE AND EXPERIENCE
Moderators:
V. Kostantinides – R. Valenti
Crackers:
M. DeBucourt – S. Ewen
| G. Boccuzzi | Is there still a role for systemic thrombolysis in the era of interventional therapy? |
| C. Fraccaro | Device selection in interventional PE treatment: matching the strategy to the patient |
| H. Kobeiter | When to act: optimizing timing and risk stratification in intermediate-high risk PE |
| P. Pruszczyk | Designing future PE trials: choosing the right efficacy and safety endpoints |
17:30 – 18:15
SESSION 8
BELOW-THE-KNEE
Expert’s Round Table
BIG ISSUES IN TREATING CLTI
Moderators:
A. Schmidt – G. Adams
Crackers:
S. Kum – B. Migliara
| S. Steiner | Heterogeneity in CLTI and how to manage it |
| A. Piaggessi | The massive impact of diabetes on CLTI-put this talk first in the session |
| E. Secemsky | BTK DCB-simolimus, paclitaxel, both or neither |
| R. Varcoe | BTK scaffolds: with drug or without, permanent or bioresorbable |
18:15
END OF THE DAY
9:00 – 9:45
SESSION 9
FEMORO-POPLITEAL
Expert’s Round Table
FOCUS ON STRATEGY
Moderators:
T. Zeller – J. Laird
Crackers:
E. Secemsky – E. Ducasse
| B. Katzen | These are the best 5 femoral-popliteal disease papers in the past year |
| M. Brodmann | My approach to SFA disease when the patient has CLTI. It differs from the approach to patients with claudication. |
| K. Deloose | Interventions for complex SFA disease in the claudicant: is it dangerous, is it worse in the long term? |
| Y. Soga | How has ISR changed in the drug eluting era: occurrence, presentation and treatment |
09:45 – 10:45
SESSION 10
VENOUS
Expert Snapshot
SYMPTOMATIC SUBCLAVIAN VEIN STENOSIS
Moderators:
B. Dolmatch – O’Sullivan
Crackers:
D. Rajan – D. Baccellieri
| M. Tozzi | Best therapies in patients with an ipsilateral AV access |
| T. Steinke | Best therapies in patients without an AV access |
| P. Kitrou | Live in the Box: subclavian vein stenosis treatment |
| G. Sengoelge | Have we learned anything about durable endovascular treatment of subclavian vein stenosis? |
10:45 -11:15
COFFEE BREAK
11:15 – 12:00
SESSION 11
BELOW-THE-KNEE
Expert’s Round Table
NEW APPROACHES AND ALGORITHMS FOR ACUTE LIMB ISCHEMIA
Moderators:
S. Kum – P. Schneider
Crackers:
A. Holden – M. Lichtenberg
| M. Palena | Percutaneous thrombectomy: review of devices and technical tips |
| E. Ducasse | Understanding fasciotomy for the interventionist |
| R. Varcoe | Is there still a role for open surgery in acute limb ischemia |
| Y. Goueffic | Evolving algorithms for when to use what tool and how to approach the patient in trouble |
12:00 – 13:00
SESSION 12
PULMONARY EMBOLISM
Expert Snapshots
INTERMEDIATE-RISK PULMONARY EMBOLISM: HOW PROTOCOL GUIDE OUR DECISIONS
Moderators:
P. Pruszczyk – A. Migliorini
Crackers:
M. Iannaccone – H. Kobeiter
| A. Rolandi | PERT activation in intermediate-risk PE: why protocols matter |
| S. Ewen | Are we closer to define the optimal treatment strategy ? |
| E. Noory | Live in the Box: Catheter-based therapy in intermediate high risk PE |
| M. De Bucourt | Large Bore Thrombectomy: Hype, Hope or Gamechanger? |
13:15 – 14:15
LUNCH BREAK
14:00 – 15:00
SESSION 13
VENOUS
Expert Snapshots
SYMPTOMATIC LEG DVT #2
Moderators:
E. Murphy – S. Black
Crackers:
B. Dolmatch – O’Sullivan
| D. Baccellieri | Top 3 complications of DVT treatment, and how they can be avoided |
| M. Lugli | Asymptomatic and symptomatic venous in-stent stenosis. When and how to intervene for durable results? |
| G. Richter | Live in the Box: DVT treatment failure |
| M. Tozzi | Are long term (>5 year) durable outcomes attainable? |
15:00 – 15:45
SESSION 14
SHOW YOUR CASE
15:45 – 16:15
COFFEE BREAK
16:15 – 17:15
SESSION 15
AV DIALYSIS FISTULA
Expert Snapshots
ADVANCES IN TREATMENT OF AVF CEPHALIC ARCH STENOSIS
Moderators:
B. Dolmatch – T. Steinke
Crackers:
O. Jaffer – M. Tozzi
| P. Kitrou | Cephalic arch stenosis – what I do |
| D. Rajan | Cephalic arch stenosis – what I do |
| R. Shahverdyan | Live in the Box: cephalic arch |
| G. Sengoelge | What the recent literature tells us |
17:15 – 18:00
SESSION 16
BELOW-THE-KNEE
Expert’s Snapshots
BTK THE FRONTIER: PEDAL ARTERY DISEASE, NO OPTION, DVA
Moderators:
M. Brodmann – A. Holden
Crackers:
K. Deloose – S. Steiner
| M. Palena | How to classify pedal disease and to do pedal angioplasty: how I do it |
| L. Patrone | Pedal intervention strategy: When is it indicated and when to add it to more proximal interventions or to stage it |
| P. Schneider | How to indentify patients who will benefit from DVA |
| B. Migliara | This is how I manage post-DVA recovery and surveillance |
18:15
END OF THE DAY
9:00 – 9:45
SESSION 17
AORTO-ILIAC
Expert’s Round Table
CURRENT MANAGMENT OF AORTO-ILIAC AND CFA DISEASE
Moderators:
F. Fanelli – P. Krishnan
Crackers:
J. Laird – B. Katzen
| K. Deloose | CERAB vs kissing-covered vs bare: What is the latest on TASC D aortoiliac? |
| G. Richter | Aortoiliac ISR: Evidence and techniques |
| E. Ducasse | CFA disease: when, why and how do I treat with endo instead of endarterectomy? |
| A. Holden | Large bore access: avoiding pitfalls, managing complications |
09:45 – 10:30
SESSION 18
VENOUS
Expert’s Round Table
DIAGNOSIS AND TREATMENT OF VENOUS PELVIC DISORDERS IN WOMEN
Moderators:
D. Rajan – D. Baccellieri
Crackers:
B. Dolmatch – G. Richter
| E. Murphy | How do you know it’s PeVD? |
| M. Lugli | Classification of PeVD: What are the types and variants? |
| tba | How is PeVD treated and what are the results? |
| G. O’Sullivan | When pelvic pain recurs after Ovarian vein embolization of PeVD, what next? |
10:30 -11:00
COFFEE BREAK
11:00 – 11:45
SESSION 19
FEMORO-POPLITEAL
Expert’s Round Table
INTENSIVE FOCUS ON POPLITEAL ARTERY
Moderators:
Y. Goueffic – S. Steiner
Crackers:
Y. Soga – T. Zeller
| A. Schmidt | My tips for crossing popliteal occlusions, including when it extends into the trifurcation |
| E. Secemsky | What are the special features of vessel prep in the poplteal artery, and when am I likely to use more than plain PTA? |
| M. Lichtenberg | The anatomy and physiology that differentiate the popliteal and factors to include in decision making |
| K. Deloose | Reconstructing the popliteal artery for isolated vs contiguous lesions and when to scaffold |
11:45 – 12:45
SESSION 20
PULMONARY EMBOLISM
Expert Snapshots
PULMONARY EMBOLISM FROM A TO Z
Moderators:
E. Noory – M. Iannacone
Crackers:
G.Boccuzzi – R. Valenti
| M. De Bucourt | What Imaging Tells Us: Anatomical and Functional Staging of PE in Interventional Planning |
| A. Migliorini | Choosing the Right Tool: Comparative Insights on available Devices |
| tba | Live in the Box: TBA |
| tba | Smarter PE Thrombectomy: Strategies to Reduce Blood Loss and Enhance Efficiency |
12:45 – 13:30
SESSION 21
BELOW-THE-KNEE
Expert Snapshots
PUTTING IT ALL TOGETHER: FUTURE OF CLTI TREATMENT
Moderators:
R. Varcoe – G. Adams
Crackers:
L. Patrone – B. Migliara
| P. Krishnan | Strategies for optimal results with CLTI |
| P. Schneider | New devices and technology for CLTI |
| M. Brodmann | This is my CLTI algorithm |
| J. Laird | My predictions for CLTI care in 10 years |
13:30
CLOSING REMARKS
F. Fanelli, P. Schneider, T. Zeller